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1. Introduction 
Recent research on the properties of enkephalins 
has expanded considerably due to interest in the prop- 
erties of analogues of the two natural pentapeptides. 
Most synthetic analogues show analgesic activity, but 
their potency varies considerably depending on the 
nature and the position of the substitutions [l-3]. 
Following the demonstration of the heterogeneous 
nature of the opiate receptor populations, we have 
studied the relationship between the chemical struc- 
ture of the enkephalin analogues and the selectivity 
for each type of receptor [4]. The results show that 
(D-Met2, N-Val’) enkephalinamide and (D-Ala’, 
N-Val’) enkephalinamide are potent agonists of opiate 
and enkephalin receptors, more active than the chem- 
ical isomers containing (Pro5) [5]. Furthermore, 
(D-Ala’) analogues can discriminate between opiate p 
receptors in guinea-pig ileum (GPI) and the predomi- 
nantly 6 receptors in mouse vas deferens (MVD) [4]. 
We now report a correlation between strong 6 receptors 
selectivity or binding and the structure induced in the 
tyrosine residue and in the peptide chain by substi- 
tution at position 5, as seen by NMR. 
2. Materials and methods 
2.1. Chemical synthesis 
The enkephalin analogues were prepared as in [5]. 
The degree of purity was checked by thin-layer chro- 
matography on silica-gel plates (ref. Merck 5626) in 
BuOH:AcOH:H20 (4: 1: 1) as solvent. RF are given in 
brackets: Tyr-D-Ala-Gly-Phe-N-Val-NH2 (0.70); 
Tyr-D-Ala-Gly-Phe-N-Val-OH (0.74); Tyr-D- 
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Ala-Gly-&e-Met-NH2 (0.68); Tyr-D-Ala-Gly- 
Phe-Met-OH (0.73). 
2.2. Preparation of samples for ‘HNMR studies 
The samples were prepared by dissolving 6 mg 
(-10 pmol) of enkephalin analogues in 0.7 ml 
(CD&SO (99.9% D), reaching -14 mM. ‘H spectra 
were recorded on a CAMECA 250 spectrometer oper- 
ating at 250 MHz. All chemical shifts are given with 
respect to tetramethylsilane, (CH&Si, which was used 
as an internal standard in all samples. 
2.3. Biological activity on isolated organs 
Isolated GPI was placed in organ baths containing 
Krebs solution and then stimulated by field stimulation 
(0.1 Hz, 0.1 ms, maximal voltage). The longitudinal 
contractions were recorded isometrically. 
The agonist potency (inhibitory effect) of enke- 
phalin analogues were tested by cumulative dose- 
response curves as in [6]. Isolated MVD was prepared 
and used as above and in [7]. 
3. Results 
Fig.1 shows the proton NMR spectra of (D-Ala’, 
N-Val’-OH) and (D-Ala’, N-Val’-NH2) in DMSO-de 
solutions containing trace amounts of water. Unam- 
bigous proton assignments were obtained from selec- 
tive irradiations performed at different temperatures 
in order to avoid overlaps and from comparisons of 
amide proton chemical shifts in preliminary separated 
studies of di- to tetrapeptides equencing the analogues 
(e.g., Tyr-D-Ala, Tyr-D-Ala-Gly and Tyr-D-Ala- 
Gly-Phe) [8]. Furthermore, the NH resonance of 
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Fig.1. ‘H NMR spectra of (D-Ala*, N-Val*) enkephalin (above) and enkephalinamide in DMSO-d,. 
D-Ala’ is easily assigned, based on the fact that the 
broadening of the signal with increasing temperature 
is the result of the proximity of the NH,+ moiety [9]. 
The water protons only appear as a broad slightly 
shifted absorption in the case of (D-Ala’, N-Val’-OH) 
and as a sharp line in the case of the amide analogue. 
Furthermore, the phenolic proton is only seen for the 
amide, at 6 = +9.40 ppm. The free acid form has over- 
lapping NH amide resonances of the Gly3, Phe4 and 
N-Val’ residues near 6 - 8.1 ppm. The amide form, 
on the other hand, shows well separated peptide NH 
resonances. In both cases, the D-Ala’NH is significantly 
shifted to lower fields. Other major differences can be 
noted in the amide compound spectrum, such as the 
resolution of the Gly3 ABX pattern near 6 - t3.6 ppm, 
and the modifications of 3JNH_Hti (table 1). The C ter- 
Table 1 
‘JNH_He (Hz) coupling constants and for (D-Ala’, N-Val’) the temperature 
dependence coefficients 0 (ppb/degree) 
D-Ala’ Gly3 Phe’ N-Val” Met* 
J 8 J B J 0 J 0 J 
D-Ala’, N-Val’-OH 7.7 3.88 4.8a 2.03 -a 1.74 7.4” 4.25 - 
D-AlaZ, N-Val’-NH, 7.3 2.70 4.4 2.51 8.5 3.17 8.1 4.22 - 
D-Ala’, Mets-OH 8.1 4.8 8.1 _ 6.6 
D-Ala*, Mets-NH, 6.6 5.3 8.1 _ 8.1 
a Approximated (Gly3 and N-Vals) or unresolved (Phe4) values 
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Table 2 
Activity of enkephalin analogues on guinea-pig ileum (GPI) and mouse vas 
deferens (MVD) 
Compound GPI MVD GPI 
ICI, (nM) IC,, (nM) __ 
MVD 
(D-Ala’, Met”)-Enkephalin 114 * 23 (3) 1.3 * 0.2 (3) 87.1 
(D-Ala’, Met’)-Enkephalinamide 39k 4 (3) 6.3 + 0.8 (5) 6.19 
(D-Ala’, N-Val’)-Enkephalin 160 + 11 (3) 2.4 r 0.2 (3) 66.6 
(D-AlaZ, N-Val’)-Enkephalinamide 40* S(6) 6.9 * 1.1 (6) 5.8 
minal amide NH2 resonances are not readily appar- 
ent in fig.1, but are located under the tyrosine and 
phenylalanine complex spectra with the help of vari- 
able temperature probe showing upfield shifts as tem- 
perature increases. 
The same general features are observed on the ‘H 
NMR spectra of (D-Ala2, Mets-OH) and (D-Ala2, Met’- 
NH2). Assignments obtained from selective irradiations 
agree well with [lo] using (D-Ala’, Mets-OH). 
The results in table 2 show that the enkephalin 
analogues are more active on MVD than GPI, bearing 
up their better activity on 6 receptors. Whatever the 
nature of the residue on position 5 (Met or N-Val), 
the presence of the amide group on the C-terminal car- 
boxylic function leads to an enhanced activity in the 
GPI assay,whereas opposite results are observed in the 
MVD assay where the amide derivatives are shown to 
be less active than the acid forms. The ratio KS,-, 
(GPI)/ICse (MVD) is therefore considerably modified 
by the amidation of the C-terminal residue which sug- 
gests a differential effect on the binding to the 2 types 
of opiate receptors present in these bioassays. 
4. Discussion 
The comparative analysis of the chemical structure 
and the biological activity have been useful to deter- 
mine the critical segments essential for the morphino- 
mimetic potency. 
Since the biological activity involves not only the 
binding to the receptor but also the metabolic stability, 
it is important to dissociate the chemical modifications 
which are implicated in the 2 events. 
The main degradation process by the aminopepti- 
dases cleaves the amide bond between tyrosine and 
glycine [lo]. The replacement of glycine by D-alanine 
decreases therefore the degradation of the pentapep- 
tides without important change of the binding to the 
2 kinds of receptors [ 12,131. Thus, the correlative 
studies between the physico-chemical parameters and 
the biological activity of (D-Ala’) analogues can be 
considered more useful to understand the essential 
parts for the binding to each kind of opiate receptors. 
Two different conformations for the acid forms 
and the amide derivatives cannot be only deduced from 
the apparent differences in chemical shifts of some 
resonances, for example in the amide region (fig.1) 
since chemical shifts are known to be sensitive to 
charge effects as well as to conformational effects [ 141. 
However, one of the most pervasive features of proton 
NMR spectra of enkephalin analogues is the impor- 
tant change in the 3JN&& coupling constant values, 
particularly in the cases of the Met’ analogues where 
we observe variations of 1.5 Hz for D-Ala’ and Met’ 
residues between acid and amide forms and, to a lesser 
extent, in the N-Val’ analogues for the valine residue 
(0.7 Hz). A set of absolute conformations can be 
obtained from the values of the coupling constant 
3JNH-Hti with the help of the Neel’s graphs [ 151; but 
we are interested, in a first step, in a more relative 
approach of the problem. If absolute 3JNH_~or values 
alone are not sufficient to determine the backbone 
conformation of either the acid or amide forms of the 
2 analogues, however, the observed variations in the 
coupling constants combined with the change in the 
chemical shifts clearly reflect differences in the con- 
formational states of the acid and amide forms of the 
2 analogues. Results on temperature-dependent chem- 
ical shift show that the Phe4 amide proton exhibits a 
quite small coefficient (<2 ppb/degree) in the acid 
form indicating a solvent shielding environment and 
possible hydrogen bonding. This has also been observed 
in [ 161. On the other hand this proton shows a normal 
exposed value (>3 ppb/degree) in the amide form. 
These unambiguous data indicate obvious differ- 
ences in the conformational states of the analogue 
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depending on the acidic or amidic forms of the C-ter- of the enkephalin analogues was necessary for strong 
minal carboxylic function. interaction with 6 receptors [ 191. 
The question of the flexibility and preferential 
(folded or extended) conformation now arises. Self 
aggregation and equilibrium between folded and 
extended conformations must be considered at the 
concentration used on this study (14 X lo9 M) 
[I 7,l S]. Low concentrations (<l 0e3 M) greatly 
diminish self-aggregation but lead to ill-resolved spec- 
tra. Investigations on concentration-dependence 
showed that spectra run over 1 O-l-1 0e3 M exhibited 
the same general features [ 81; this allows us such a 
comparative study with minimal effects of self-associ- 
ation at >109 M. ‘Head-to-tail’ interactions are well 
known for zwitterionic forms of the enkephalins and 
their carboxylic acid analogues. The mobility of the 
side chains of the tyrosyl and phenylalanyl residues 
can transfer to the peptidic backbone a relative flexi- 
bility, leading to possible conformational averaging. 
The lack of resonance for the phenolic proton of 
tyrosine, at low field of the spectrum, resulting from 
a rapid exchange with the protons of water present in 
the solution can be explained by a ‘self-catalysis’ 
mechanism, occurring through the carboxylic func- 
tion, allowed by the flexibility of the molecule. 
We report here that the effect of the amidation is 
more complex and that an increase of rigidity of the 
peptidic backbone can be considered. Such rigidity 
strongly increases the activity on /1 receptors whereas 
it decreases the potency on 6 receptors [20]. The 
increase of rigidity could explain the pharmacological 
variations rf the biological activity which lead to the 
increase of the p agonist activity and to the decrease 
of the 6 agonist potency. 
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